Melbourne, Victoria, Australia
Trajan Scientific and Medical (Trajan) has been featured by @AuManufacturing, highlighting Trajan's ongoing investment into the development of hemaPEN®, and other technologies to address emerging trends in healthcare.
The article outlines Trajan's collaborative approach to R&D, and success in identifying and manufacturing niche technologies for global markets.
Read the full article at @AUManufacturing - Pens and prospering as a manufacturer.
The hemaPEN® is a device supplied for research purposes only. This device is not for therapeutic or diagnostic use.
Trajan Scientific and Medical’s (Trajan) highly successful ASTech1 program has resulted in the commercial development of several new syringe technologies. The program was developed in collaboration with the University of Tasmania where the objective was to develop a range of “lab-in-a-syringe” applications, expanding on Trajan’s expertise in precision manufacturing of their industry leading analytical syringe portfolio.